Insider buying last 90 days
No open-market insider purchases were filed for BTSG in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every BTSG insider filing, plotted on the chart in Gekko.Open BTSG in Gekko
NASDAQ: BTSG
BrightSpring Health Services (BTSG) Stock Analysis & Forecast
Sep 28 close
$56.54−0.05 (−0.1%)
Gekko Brief
AI summaryThis week, BrightSpring Health Services (BTSG) outlined its growth strategy at the Bernstein healthcare services conference, pointing to specialty pharmacy expansion, home health acquisitions, technology investments and integration of services for complex patients. Separately, commentary highlighted improved operating cash flow and reduced leverage following Q2 2026 results, framing this financial position as supportive of future mergers and acquisitions activity.
BTSG closed at $56.54, down 0.1%, sitting between its 50-day average of $61.56 and 200-day average of $51.86. The one-month return stands at -7.2% and the three-month return at -18%, while the six-month return is 33.6% and the one-year return is 110.6%. The GekkoIndex reads 64.2, placing the stock in the Accumulation zone, though the index has slipped 4.1 points over five sessions. Price sits 7.4% below Gekko Fair Value of $61.08.
The next earnings report is scheduled for 29 October 2026, before the open, 30 days out and outside a typical 20-trading-day holding window. The prior report, on 31 July 2026, saw EPS of $0.45 against a $0.37 estimate, with a -17% reaction, part of a pattern of 5 beats in the last 8 quarters and an average absolute reaction of 10%. Analyst coverage from 15 firms is unanimously rated buy, with a consensus target of $78.94, implying 39.6% consensus upside. Holdings include one billionaire holder and one trailblazer holder; no insider, Congress or unusual options activity is recorded in the respective windows.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
BrightSpring Health Services price vs fair value
Close $56.54200-day averageGekko Fair Value $61.08
BrightSpring Health Services quick facts
- Market cap
- $11.10B
- P/E ratio
- 50.5
- Forward P/E
- 22.2
- EPS, TTM
- $1.12
- Revenue, TTM
- $14.37B
- Profit margin
- 2.6%
- Dividend yield
- —
- Beta
- 1.85
- Volume
- 2.03M avg 2.53M
- 1-year return
- +110.6%
- Typical daily move
- ±3.7%
- Typical 20-day move
- ±10.3%
- 50-day average
- $61.56
- 200-day average
- $51.86
- Next earnings
- Oct 29 before open
- Shares outstanding
- 197.9M
BrightSpring Health Services swing-trade checklist
BrightSpring Health Services scores 3 supportive, 1 mixed and 0 headwinds across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed0 headwinds
- Trendmixed
Averages disagree
Close $56.54 sits between the 50-day ($61.56) and 200-day ($51.86) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
64.2, Accumulation
Reading 64.2 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
7.4% below
Price is 7.4% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 30 days
Next report Oct 29, 2026, 30 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityno data
No data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
BrightSpring Health Services stock chart and price history
BrightSpring Health Services closed at $56.54 on Sep 28, 2026, +110.6% over the past year, inside a 52-week range of $26.35 to $73.75.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −7.2%
- 3 months
- −18.0%
- 6 months
- +33.6%
- 1 year
- +110.6%
The full BTSG chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open BTSG in Gekko
Follow BrightSpring Health Services through every session
Put BTSG on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track BTSG in GekkoFree for 7 days. No credit card required.
About BrightSpring Health Services
BrightSpring Health Services provides healthcare services delivered in patients' homes and local communities across the United States. Its work centers on pharmacy services alongside medical provider support, combining clinical treatment with everyday assistance for those who need it. The company is recognized for bringing this kind of home and community based care to a wide range of patients rather than requiring facility visits.
Care is delivered by clinical staff and licensed pharmacists who work directly with patients. The people served include those covered by Medicare, Medicaid, and private insurance plans, reflecting a customer base that spans public and private payers.
The company was founded in 1974 and is headquartered in Louisville, Kentucky. It previously operated under the name Phoenix Parent Holdings Inc. before adopting its current name, BrightSpring Health Services, Inc., in May 2021. Shares of the company are listed on the NASDAQ under the ticker BTSG.
- Listed
- NASDAQ
- Sector
- Health services
- Industry
- Medical/Nursing services
- Website
- brightspringhealth.com
BrightSpring Health Services GekkoIndex: the smart money zone
BrightSpring Health Services’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 64.2, in the Accumulation zone, down 4.1 points over five sessions.
64.2Accumulation
Down 4.1 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 15 | +3.1% | +6.6% | ||
| Accumulation (current zone) | 148 | +0.5% | +11.4% | ||
| Neutral | 407 | +1.6% | +5.0% | ||
| Distribution | 89 | +1.7% | +4.7% | ||
| Selling | 5 | Too few readings yet | |||
Average BTSG share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the BTSG price, zone by zone.Track BTSG in Gekko
Is BrightSpring Health Services stock overvalued? Gekko Fair Value
BrightSpring Health Services trades 7.4% below Gekko Fair Value of $61.08, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what BrightSpring Health Services shares are worth, recalculated every trading day.
$61.08
Gekko Fair Value, Sep 29, 2026
7.4% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open BTSG in Gekko
BrightSpring Health Services insider and Congress trading
No open-market insider purchases were filed for BrightSpring Health Services, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in BTSG were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for BTSG, plotted on the chart in Gekko.Open BTSG in Gekko
Buybacks
BrightSpring Health Services has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $60.00M
- As a share of market cap
- 0.54%
From company filings.
Hedge funds and billionaires quarter ended Jun 30
2of the funds Gekko tracks hold BTSG.
0added1opened1trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
BrightSpring Health Services earnings: next date and track record
BrightSpring Health Services reports on Oct 29, 2026, before the open (30 days away), and beat the EPS estimate in 5 of its last 8 reports.
Next earnings report
Oct 29, 2026
Expected before the open, 30 days away
- EPS estimate
- $0.46
- Revenue estimate
- $3.86B
5 of 8reports beat the EPS estimate
±10%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 31, 2026 AI summary
- What they said
- BrightSpring Health Services Q2 2026 earnings call: Management (CEO Jon Rousseau and CFO Jennifer Phipps) highlighted strong Q2 financial performance with revenue of $3.9B (+23% YoY) and adjusted EBITDA of $206M (+44% YoY). Pharmacy Solutions drove the majority of revenue ($3.4B, +22% YoY) with Specialty and Infusion performing well (Specialty & Infusion revenue $2.9B, +30% YoY). Provider Services revenue was $466M (+30% YoY) with Home Health Care up 51% YoY, driven by census growth, de novo expansions and acquired branches (Amedisys/LHC). Management emphasized growth drivers: LDD wins (12 YTD), fee-for-service wraparound programs, AI/automation investments, strong operational execution, tuck-in M&A pipeline, and capital allocation flexibility after Community Living divestiture. They noted IRA (Inflation Reduction Act) impacts: Home & Community Pharmacy revenue reduction of approximately $200M for full-year 2026 (~$50M per quarter) with EBITDA impact of about $15M for the year; Specialty revenue headwind ~ $175M but minimal EBITDA impact. Management reiterated confidence in operations, margin stability, and continued quarter-over-quarter growth for balance of 2026. Several analyst questions covered generics, gross margin seasonality, Infusion chronic vs acute growth, LDD ramp, tariff risks, capital structure and M&A, selling efforts and retention drivers. Closing remarks were positive and forward-looking.
- Guidance
- Management provided forward-looking directional guidance: they expect quarter-over-quarter growth for the remainder of 2026 with Q3 and Q4 growth similar to each other. They quantified IRA impacts for 2026: Home & Community Pharmacy revenue headwind of ~$200M for the year (~$45–50M per remaining quarter) and EBITDA impact of ~$15M for the year in Home & Community; Specialty revenue headwind of ~$175M with minimal EBITDA impact. They reiterated leverage at 2.15x and implied strong OCF (> $600M expected for the year) and robust free cash flow. CFO noted continued flexibility to pursue M&A with a robust pipeline.
- Risks flagged
- Risk factors mentioned included IRA-related revenue headwinds (2026 ~$200M Home & Community; ~$175M Specialty), potential future generic tariffs (tariff risk pushed to 2028), and legislative/regulatory uncertainty impacting pricing and reimbursement. Management also noted competitive dynamics and valuation inflation in M&A markets as a discipline risk for acquisition activity.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 31, 2026 | $0.45 est $0.37 | $3.87B est $3.66B | −17.0% |
| May 1, 2026 | $0.39 est $0.31 | $3.61B est $3.39B | +11.6% |
| Feb 27, 2026 | $0.33 est $0.25 | $3.55B est $3.38B | +3.6% |
| Oct 31, 2025 | $0.30 est $0.26 | $3.33B est $3.17B | +2.1% |
| Aug 1, 2025 | $0.13 est $0.22 | $3.15B est $3.17B | −6.2% |
| May 2, 2025 | $0.19 est $0.08 | $2.88B est $2.90B | +18.2% |
| Nov 1, 2024 | $0.11 est $0.17 | $2.91B est $2.94B | +12.3% |
| Aug 2, 2024 | $0.10 est $0.17 | $2.73B est $2.72B | −8.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
BrightSpring Health Services stock forecast and analyst price targets
Analysts’ average 12-month price target for BrightSpring Health Services is $78.94, +39.6% from the last close, from 15 firms rating the stock in the last 90 days.
$78.94consensus 12-month target, +39.6% from the last close
Now $56.54Avg $78.94
Low $70High $90
Each firm’s latest rating in the last 90 days: 15 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 17 | BMO Capital | $70 | +23.8% |
| Sep 17 | Jefferies | $87 | +53.9% |
| Sep 9 | UBS | $85 | +50.3% |
| Aug 19 | TD Cowen | $81 | +43.3% |
| Aug 3 | Deutsche Bank | $70 | +23.8% |
+11.4%average 20-day move after past Accumulation readings
±3.7%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
BrightSpring Health Services market cap and key statistics
BrightSpring Health Services’s market cap is $11.10B, with a P/E ratio of 50.5 and revenue of $14.37B over the last twelve months.
Valuation
- Market cap
- $11.10B
- P/E ratio
- 50.5
- Forward P/E
- 22.2
- EPS, TTM
- $1.12
- Gekko Fair Value
- $61.08
Trading
- Volume
- 2.03M
- Avg volume, 20 days
- 2.53M
- 52-week high
- $73.75
- 52-week low
- $26.35
- Shares outstanding
- 197.9M
Financials
- Revenue, TTM
- $14.37B
- Profit margin
- 2.6%
- Return on equity
- 13%
- Quarterly earnings growth, YoY
- +196.6%
Risk and income
- Beta
- 1.85
- Typical daily move
- ±3.7%
- Typical 20-day move
- ±10.3%
BrightSpring Health Services stock news this week
2 headlines about BrightSpring Health Services from the past week, newest first, each linking to the publisher.
- BrightSpring Health Targets Growth Through Specialty Pharmacy, M&A and AIDefense World, Sep 28
- Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve?TradingView, Sep 25
BrightSpring Health Services peers
BrightSpring Health Services’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LHLabcorp | Accumulation | 3.9% below |
| GHGuardant Health | Neutral | 0.5% above |
| SOLVSolventum | Neutral | 16.4% below |
| EHCEncompass Health | Neutral | 7.6% above |
| DVADaVita | Accumulation | 15.9% below |
| ENSGEnsign | Neutral | 11.2% above |
A peer links to its own page where one exists.
BrightSpring Health Services stock FAQ
What is BrightSpring Health Services’s market cap?
BrightSpring Health Services’s market cap is $11.10B at the Sep 28, 2026 close of $56.54, with 197.9M shares outstanding. The shares trade on a P/E ratio of 50.5.
What is the BrightSpring Health Services stock forecast?
The consensus analyst 12-month price target for BrightSpring Health Services is $78.94, +39.6% from the last close. Of the 15 firms that rated the stock in the last 90 days, 15 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is BrightSpring Health Services stock overvalued or undervalued?
On Gekko’s estimate BrightSpring Health Services is undervalued: the Sep 28, 2026 close of $56.54 is 7.4% below Gekko Fair Value of $61.08. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does BrightSpring Health Services report earnings next?
BrightSpring Health Services is expected to report on Oct 29, 2026, before the market opens (30 days away). Analysts expect earnings of $0.46 per share on revenue of $3.86B. BrightSpring Health Services beat the earnings estimate in 5 of its last 8 reports, moving 10% on average across the report.
What is BrightSpring Health Services’s 52-week high and low?
BrightSpring Health Services’s 52-week high is $73.75 and its 52-week low is $26.35; it closed at $56.54 on Sep 28, 2026, +110.6% over the past year.
Is BrightSpring Health Services stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 4 items with data read as supportive (gekkoindex, fair value and earnings risk), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See BrightSpring Health Services the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.